IO Biotech Inc (IOBT) Peer Comparison

$0.01

$0.00 (3.66%)

As on 08-Jun-2026 09:30EDT

Market cap

$3 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Edit

	IO Biotech Inc (IOBT)	Janone Inc (JAN)
Market cap ($ Mln)	3	9,529
Revenue ($ Mln)	1	771
Net Profit ($ Mln)	-88.35	-61.10
Net Margin (%)	-10,394.00	--
RoE (%)	-646.46	-3.97
Price to Earnings	--	--
Price-To-Book	0.65	2.62

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	IO Biotech Inc (IOBT)	Janone Inc (JAN)
Operating Revenue	0.85	568.48
Cost of Revenue	0.91	1.50
Gross Profit	-0.85	568.48
Operating Expenses	91.14	579.55
Operating Profit (EBIT)	-92.05	-11.08
Other Income	0.00	--
Profit before Tax	-89.30	-63.85
Provision for Tax	-0.96	-13.38
Profit after Tax (Net Income)	-88.35	-50.46
Minority Interest	0.00	--
Consolidated Profit	0.00	--

Liabilities ($ Mln)

	IO Biotech Inc (IOBT)	Janone Inc (JAN)
Shareholder's Funds	0.91	1,308.85
Minority Interest	0.00	--
Non-Current Liabilities	20.73	106.25
Current Liabilities	18.31	928.20
Total Liabilities	67.70	2,343.30

Assets ($ Mln)

	IO Biotech Inc (IOBT)	Janone Inc (JAN)
Non-Current Assets	3.13	2,163.43
Current Assets	36.83	179.87
Total Assets	67.70	2,343.30
Total Debt*	1.46	106.25
Net Current Assets	18.52	-748.33

Cashflow ($ Mln)

	IO Biotech Inc (IOBT)	Janone Inc (JAN)
Cash From Operating Activities	-82.35	128.56
Cash Flow from Investing Activities	-0.04	-44.11
Cash from Financing Activities	0.00	-82.34
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	IO Biotech Inc (IOBT)	Janone Inc (JAN)
ROCE (%)	-103.47	-7.07
ROE (%)	-646.46	-7.65
ROA (%)	-107.57	-4.27
EBIT Margin (%)	-10,372.35	--
Net Margin (%)	-10,394.00	-8.88
Cash Profit Margin (%)	-0.01	--

Growth Ratios

	IO Biotech Inc (IOBT)	Janone Inc (JAN)
Revenue Growth (%)	-23.42	13.35
EBIT Growth (%)	0.93	--
Net Profit Growth (%)	2.20	-151.56
EPS Growth (%)	2.35	--
Book Value Growth (%)	-98.76	--

Valuation Ratios

	IO Biotech Inc (IOBT)	Janone Inc (JAN)
Price / Earnings	-0.63	--
Price / Book Value	1.29	--
Dividend Yield (%)	--	--
EV/EBITDA	-0.03	-0.22
Market Cap ($ Cr)	--	--

Solvency Ratios

	IO Biotech Inc (IOBT)	Janone Inc (JAN)
Debt to Equity	18.29	0.08
Short term debt to equity ratio	0.86	--
Current Ratio	2.01	0.19
Quick Ratio	2.01	--
Interest Coverage	-77.41	-15.20

Operating Efficiency Ratios

	IO Biotech Inc (IOBT)	Janone Inc (JAN)
Debtors to sales (%)	116.59	17.73
Asset Turnover	0.01	0.48
Receivable days	--	32.47
Inventory Days	--	89.12
Payable days	1,836.79	1,092.22
Cash Conversion Cycle	--	-965.35

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly